CURI BIO INC
- SEATTLE, WA 98121-1023
- curibio.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM expiring
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $17K
- Awards on record
- 1
- Contract vehicles
- 0
- Verified credentials
- 0
SAM.gov registration expires in 54 days
CURI BIO INC’s registration expires on Jan 6, 2027. Renewal can take weeks; confirm it stays active through proposal submission and award.
View on SAM.gov (opens in a new tab)Learn more about SAM registration and the UEI
About CURI BIO INC
- Headquarters
- SEATTLE, WA 98121-1023
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEID6VABZ7RVM84
- CAGE7C8Q3
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $17K
- Awards on record
- 1
- Top funding agencies
- National Institutes of Health
Awards
75N95024P00504
Completed: Period of performance ended Sep 17, 20243D IPSC SKELETAL MUSCLE MEDIA KITS
Department of Health and Human Services · National Institutes of Health
- Obligated
- $17K
- Period of performance
- Sep 4, 2024 – Sep 17, 2024
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
75N95024P00504 3D IPSC SKELETAL MUSCLE MEDIA KITS | Department of Health and Human Services · National Institutes of Health | 325414 · 6505DRUGS AND BIOLOGICALS | $17K | Sep 4, 2024 – Sep 17, 2024 | Completed: Period of performance ended Sep 17, 2024 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 16 awards
- Total awarded
- $11,985,726
- By phase
- SBIR Phase I: 11
- SBIR Phase II: 5
- By agency
- Department of Health and Human Services: 16
- Active projects
- 1 project
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 1 project
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2024: 2
- 2023: 2
- 2021: 1
- 2020: 4
- 2019: 4
- 2018: 1
- 2017: 1
- 2016: 1
Awards (most recent first)
High-Throughput NMJ Assay for Botox Potency Screening
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2024 · $1,811,194
Feb 1, 2024 – Jan 31, 2026
Solicitation TR22-032 (2022) · Topic 300
A cross-species preclinical platform to enhance the translation of new medicines
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2024 · $1,982,136
Dec 1, 2023 – Nov 30, 2026
- Active
- Ends Nov 2026
Solicitation PA22-176 (2022) · Topic 100
High-Throughput NMJ Assay for Botox Potency Screening
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2023 · $275,766
Aug 1, 2023 – Jan 31, 2024
Solicitation TR22-032 (2022) · Topic NCATS
A cross-species preclinical platform to enhance the translation of new medicines
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2023 · $324,648
Jun 1, 2023 – Nov 30, 2023
Solicitation PA22-176 (2022) · Topic 100
Predictive assessment of acute and chronic cardiotoxicity using combinatorially matured hPSC-CMs
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2021 · $2,034,388
Sep 1, 2021 – Aug 31, 2024
Solicitation PA21-345 (2019) · Topic NHLBI
Cryopreserving Stem Cell-Derived Cardiomyocytes in Ready-to-use Assay Plates for Improved Reproducibility of Drug Toxicity Testing
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2020 · $252,131
Sep 11, 2020 – Feb 28, 2021
Solicitation PA19-272 (2019) · Topic NHLBI
Maturation of stem cell-derived cardiomyocytes using a simulated microgravity bioreactor and combinations of extracellular developmental cues
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2020 · $252,131
Aug 1, 2020 – Jan 31, 2021
Solicitation PA19-272 (2019) · Topic NHLBI
Predictive assessment of acute and chronic cardiotoxicity using combinatorially matured hPSC-CMs
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2020 · $225,000
Aug 1, 2020 – Jan 31, 2021
Solicitation PA18-574 (2018) · Topic NHLBI
Bioengineering Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes for Predictive Drug-Induced Toxicity Testing
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2020 · $1,743,756
Jun 5, 2020 – May 31, 2022
Solicitation PA18-574 (2018) · Topic NHLBI
Multiplexed quantitative measurements of field potential and contractility on biomimetically-matured hPSC-CMs
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $225,000
Sep 16, 2019 – Mar 31, 2020
Solicitation PA18-574 (2018) · Topic NIBIB
Low-cost, Roll-to-Roll Manufacturing of Nanoscale Biomimetic Scaffolds for Enhanced Biological Cell Culture
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $221,713
Sep 15, 2019 – Sep 14, 2020
Solicitation PA18-574 (2018) · Topic NIBIB
Bioengineering Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes for Predictive Drug-Induced Toxicity Testing
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $225,000
Sep 1, 2019 – Mar 31, 2020
Solicitation PA18-574 (2018) · Topic NHLBI
A Combinatorial Bioreactor for Electromechanical Conditioning of Differentiated Stem Cells
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $225,000
May 20, 2019 – Apr 20, 2020
Solicitation PA18-574 (2018) · Topic NHLBI
High-throughput nanoMEA-based Proarrhythmia Assay
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2018 · $1,748,863
Sep 25, 2018 – Jun 30, 2020
Solicitation PA18-837 (2018) · Topic NHLBI
A Nanopatterned Interdigitated Electrode Array Device for Anti migratory Cancer Drug Screening
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2017 · $225,000
Sep 21, 2017 – Jun 20, 2018
Solicitation PA16-302 (2016) · Topic 102
High-throughput nanoMEA-based Proarrhythmia Assay
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2016 · $214,000
Sep 1, 2016 – Aug 31, 2017
Solicitation PA14-071 (2015) · Topic NHLBI
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 334516Analytical Laboratory Instrument ManufacturingPrimary
- 325414Biological Product (except Diagnostic) Manufacturing
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov does not report this entity as small under any listed NAICS code.
Socio-economic status
No socio-economic certifications reported in SAM.gov.
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with CURI BIO INC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.